grant
Oklahoma Center of ImmunoEngineering (OCIE)
Organization UNIVERSITY OF OKLAHOMALocation NORMAN, UNITED STATESPosted 15 May 2026Deadline 31 Jan 2031
NIHUS FederalResearch GrantFY20262019-nCoV vaccineAI systemAccelerationAddressAntigen-Antibody ComplexApplications GrantsArtificial IntelligenceBasic ResearchBasic ScienceBody SystemCAR T cell therapyCAR T therapyCOBRECOVID-19 vaccineCancer TreatmentCancersCell BodyCellsCenter of Biomedical Research ExcellenceCenters of Research ExcellenceClinicalClinical SciencesCollaborationsCommunitiesComputer ModelsComputer ReasoningComputerized ModelsDataData AnalysesData AnalysisData CollectionData ScienceData Science CoreData Science Resource CoreDevelopmentDiabetes MellitusDisciplineDiseaseDisorderEducational workshopEngineeringEnsureEquipmentExperimental DesignsFacultyFosteringFoundationsFundingFutureGenerationsGenetic EngineeringGenetic Engineering BiotechnologyGenetic Engineering Molecular BiologyGenomicsGeographyGoalsGrantGrant ProposalsHealthHealth SciencesHuman ResourcesImmune ComplexImmune systemImmunochemical ImmunologicImmunogenomicsImmunologicImmunologicalImmunologicallyImmunologicsImmunomodulationInfrastructureInstitutionInvestigatorsMachine IntelligenceMachine LearningMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorManpowerManuscriptsMedical ResearchMentorsMethodsModelingModernizationMonitorMultiomic DataNational Institutes of HealthNetwork AnalysisOklahomaOrgan SystemOrganellesPathway AnalysisPhasePilot ProjectsPreparationProteomicsPublicationsR-Series Research ProjectsR01 MechanismR01 ProgramRNA vaccineRNA-based vaccineRecombinant DNA TechnologyReportingResearchResearch GrantsResearch InfrastructureResearch PersonnelResearch PriorityResearch Project GrantsResearch ProjectsResearch ResourcesResearch SupportResearchersResourcesReverse engineeringSARS-CoV-2 vaccineSARS-coronavirus-2 vaccineScienceScientific PublicationServicesSevere Acute Respiratory Syndrome CoV 2 vaccineSevere acute respiratory syndrome coronavirus 2 vaccineSingle cell seqTechnical ExpertiseTechnologyTrainingTranslational ResearchTranslational ScienceUnited States National Institutes of HealthUniversitiesViral DiseasesVirusVirus DiseasesWorkshopanalytical toolanti-cancer therapycancer therapycancer-directed therapycareercareer developmentcheck point blockadecheckpoint blockadechimeric antigen receptor (CAR) T cell therapychimeric antigen receptor T cell therapychimeric antigen receptor T therapycombatcomputational modelingcomputational modelscomputer based modelscomputerized modelingconferenceconventioncoronavirus disease 2019 vaccinecoronavirus disease-19 vaccinedata acquisitiondata acquisitionsdata integrationdata interpretationdata visualizationdevelopmentaldiabetesengineered immune systemexperiencegenetically engineeredimmune check point blockadeimmune checkpoint blockadeimmune engineeringimmune modulationimmune regulationimmunoengineeringimmunologic reactivity controlimmunomodulatoryimmunoregulationimmunoregulatoryinnovateinnovationinnovativeinstrumentationinternet resourcemRNA vaccinemRNA-based vaccinemachine based learningmachine learning based methodmachine learning methodmachine learning methodologiesmalignancymicrobial consortiamicrobial floramicrobiotamicrofloramultiomicsmultiple omic datamultiple omicsmultispecies consortianCoV vaccinenCoV-19 vaccinenCoV19 vaccineneoplasm/cancernew approachesnew technologynovelnovel approachesnovel strategiesnovel strategynovel technologieson-line compendiumon-line resourceonline compendiumonline resourcepanomicsparallel computationparallel computerparallel computingpersonnelpilot studypreparationsprogramssingle cell next generation sequencingsingle cell sequencingsummitsymposiasymposiumsynergismtechnical skillstooltranscriptomicstranslation researchtranslational investigationvaccine against 2019-nCovvaccine against COVID-19vaccine against SARS-CoV-2vaccine against SARS-coronavirus-2vaccine against Severe Acute Respiratory Syndrome CoV 2vaccine against Severe acute respiratory syndrome coronavirus 2vaccine candidates against SARS-CoV-2vaccine for novel coronavirusvaccines preventing COVIDvaccines to prevent COVIDviral infectionvirus infectionvirus-induced diseaseweb resourceweb-based resource
Description preview
Project Summary / Abstract – Overall Component
This NIH Phase I COBRE program aims to establish the Oklahoma Center of ImmunoEngineering (OCIE).
OCIE will facilitate the convergence of immunomodulation and omics data science research, support the career
development of Research Project Leaders (RPLs) and other immunoengineering researchers, and…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click